Clinical Research
An overview of scientific studies investigating the alkaloid profile, neurochemical activity, and functional wellbeing applications of Sceletium tortuosum.
Overview of Research Landscape
Scientific research on Sceletium tortuosum has primarily focused on:
While many studies are preclinical or exploratory, collectively they provide a foundational scientific rationale supporting the traditional use of Sceletium for emotional and mental wellbeing.
Preclinical and Exploratory Studies
Preclinical Study
Mesembrine-Type Alkaloids and Mood-Related Pathways
A preclinical study by Schell (2014) investigated behavioural effects of mesembrine-type alkaloids in BALB/c mice, comparing extracts with varying alkaloid composition to a reference pharmaceutical compound.
The study explored behavioural markers commonly used in mood-related research models and reported activity comparable to the reference substance within the experimental framework. While not indicative of clinical outcomes, the findings contributed to early scientific interest in the neuroactive properties of these alkaloids.
Reference: Schell (2014).
Review & Investigations
Pharmacological and Neurophysiological Investigations
The review “A Chewable Cure ‘Kanna’: Biological and Pharmaceutical Properties of Sceletium tortuosum” (Smith et al., 2021) summarises multiple in-vitro, in-vivo, and limited human studies evaluating the plant’s pharmacological characteristics.
- Experimental models related to mood and stress response have been explored.
- EEG and related neurophysiological markers suggest potential influence on patterns associated with relaxation and sensory processing.
- Observed effects support continued investigation into calmness and emotional balance.
Importantly, these findings are exploratory and further controlled human studies are required to substantiate functional outcomes.
Reference: Smith et al. (2021).
Human Observational and Pilot Studies
Literature summary (Gericke & Viljoen, 2008)
An updated review, “Sceletium — A Review Update” (Gericke & Viljoen, 2008), compiles historical and contemporary data on Sceletium research. Among the cited work is a small observational human case series (Gericke, 2001), in which Sceletium preparations were administered under supervised conditions.
Participants were observed for changes in mood, anxiety, and daily functioning. The review reports positive trends in subjective wellbeing and emotional state, while clearly acknowledging the limited sample size and exploratory nature of the data.
These early human observations informed subsequent research directions but are not intended to support therapeutic claims.
References: Gericke (2001); Gericke & Viljoen (2008).
Summary
Summary of Scientific Interpretation
Collectively, the available scientific literature suggests that Sceletium tortuosum contains bioactive alkaloids that interact with neurochemical pathways relevant to stress perception, mood regulation, and emotional balance.
While the evidence base includes preclinical, mechanistic, and limited human data, it provides a credible foundation for positioning Sceletium as a botanical ingredient for wellbeing support, rather than as a medicinal or therapeutic agent.
No claims are made to diagnose, treat, cure, or prevent any disease.
Request Technical Information
Scientific references, supporting literature, and technical documentation are available upon request. Contact our team for further information or partnership enquiries.